Premium
38 mm Stents: Go Big and Go Long
Author(s) -
Seto Arnold H.,
Kern Morton J.
Publication year - 2015
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.25761
Subject(s) - medicine , restenosis , stent , coronary restenosis , everolimus , randomized controlled trial , drug eluting stent , population , surgery , environmental health
Key Points This article demonstrates the safety and effectiveness of using the 38 mm Xience Prime (Abbott Vascular) everolimus‐eluting stent in an unselected real‐world population over one year. This work may alleviate concerns of stent thrombosis or restenosis with long second‐generation drug‐eluting stents. Prospective, randomized trials would provide more clear evidence that long stents are safe.